60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed Apr 1, 2024 · 10-K · 92 days after period end · 0001213900-24-028577
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|
| Revenue | $125.68K | — |
| Net Income | -$2.01M | -$1.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Apr 1, 2024 · 92 d after period end
